Stephen Forman
Institution Name:
City of Hope, Beckman Research Institute
Total Awards:
1
Award Value:
$5,215,447
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Early Translational III | City of Hope, Beckman Research Institute | Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells | $5,215,447 |
Total: $5,215,447.00 |
Publications
- Clin Cancer Res 2015 Bioactivity and Safety of IL13Ralpha2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma. (PubMed: 26059190)
- Curr Opin Oncol 2015 Smart CARs engineered for cancer immunotherapy. (PubMed: 26352543)
- N Engl J Med 2016 Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. (PubMed: 28029927)
- Mol Ther 2018 Optimization of IL13Ralpha2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma. (PubMed: 29103912)